Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00192382PMID 8665998
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetics of allopurinol after single intravenous and oral doses

  2004cited by this paper
• Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting.

  1994cited by this paper
• New uses for allopurinol.

  1994cited by this paper
• A new approach to the treatment of nonsteroidal anti-inflammatory drugs induced gastric bleeding by free radical scavengers.

  1993cited by this paper
• The relationship between Helicobacter pylori and oxygen-derived free radicals in the mechanism of duodenal ulceration.

  1993cited by this paper
• A new approach to the treatment of nonsteroidal anti-inflammatory drugs induced gastric bleeding by free radical scavengers.

  1993cited by this paper
• Simultaneous determination of allopurinol and oxipurinol in human plasma and urine by high-performance liquid chromatography.

  1993cited by this paper
• Bioequivalence of allopurinol preparations: to be assessed by the parent drug or the active metabolite?

  1993cited by this paper
• A randomized controlled trial of allopurinol in coronary bypass surgery.

  1991cited by this paper
• Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites.

  1991cited by this paper
• The significance of nutrition for the bio-pharmaceutical characteristics of oral controlled release products and enteric coated dosage forms

  1989cited by this paper
• Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.

  1988cited by this paper
• The development of allopurinol.

  1985cited by this paper
• Oxipurinol therapy in allopurinol-allergic patients.

  1983cited by this paper
• Pharmacology of allopurinol.

  1975cited by this paper
• Drugs in the treatment of hyperuricemia.

  1974cited by this paper
• Drugs in the treatment of hyperuricemia.

  1974cited by this paper
• A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.

  1968cited by this paper
• Renal clearance of oxipurinol, the chief metabolite of allopurinol.

  1968cited by this paper
• Metabolic Effects of Allopurinol and Allo-Xanthine

  1966cited by this paper

• History of Treatments Used to Treat Gout and Hyperuricemia

  2023cites this paper
• Developing, optimizing and assessing a green electrophoretic method for determination of Benzbromarone and Allopurinol with its active metabolite in biological and pharmaceutical matrices.

  2021cites this paper
• Gout

  2019cites this paper
• Liquid Chromatograph – Mass Spectrophotometer and Anti Uric Acid Potential Studies of Ethyl Acetat Extract of Archidendron bubalinum (Jack) I.C. Nielsen Fruit Seed Shell

  2018cites this paper
• Development and Validation of Different Chromatographic Methods for Determination of Two Hypouricemic Drugs in Their Combined Dosage Form

  2014cites this paper
• Spectrophotometric Methods for Simultaneous Determination of Two Hypouricemic Drugs in their Combined Dosage Form

  2013cites this paper
• The pharmacokinetics of oxypurinol in people with gout.

  2012cites this paper
• Gout

  2011cites this paper
• British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.

  2007cites this paper
• Studies on Bi-Layer Osmotic Pump Tablets of Water-Insoluble Allopurinol with Large Dose: In Vitro and In Vivo

  2007cites this paper
• Clinical trials in crystal arthropathy.

  2006cites this paper
• Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics

  2006cites this paper
• A concise history of gout and hyperuricemia and their treatment

  2006cites this paper
• Case 8: initiation of urate-lowering therapy for standard advanced gout.

  2006cites this paper
• Review Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic

  2006cites this paper
• Gout: on the brink of novel therapeutic options for an ancient disease.

  2004cites this paper
• Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failure

  2004cites this paper
• Clinical practice. Gout.

  2003cites this paper
• Effect of Allopurinol Pretreatment on Free Radical Generation after Primary Coronary Angioplasty for Acute Myocardial Infarction

  2003cites this paper
• Bioequivalence of allopurinol and its metabolite oxipurinol in two tablet formulations

  2001cites this paper
• Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects.

  1999cites this paper
• NITRIC OXIDE‐DEPENDENT ENDOTHELIAL FUNCTION IS UNAFFECTED BY ALLOPURINOL IN HYPERCHOLESTEROLAEMIC SUBJECTS

  1999cites this paper
• [The bioequivalence of a new allopurinol tablet formulation in comparison to a reference formulation].

  1997cites this paper
• Uric acid lowering effect of oxipurinol sodium in hyperuricemic patients - therapeutic equivalence to allopurinol.

  1996cites this paper